<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="jpd-10-jpd191775-t001" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Demographic and clinical variables collected in the Quebec Parkinson Network</p>
 </caption>
 <table frame="hsides" rules="groups">
  <colgroup span="1">
   <col align="left" span="1"/>
   <col align="center" span="1"/>
  </colgroup>
  <thead valign="top">
   <tr>
    <td rowspan="1" colspan="1">Demographic data</td>
    <td rowspan="1" colspan="1">Clinical data</td>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="1" colspan="1">•Sex</td>
    <td rowspan="1" colspan="1">•Date of symptom onset</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Date of birth</td>
    <td rowspan="1" colspan="1">•Date of diagnosis</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Laterality</td>
    <td rowspan="1" colspan="1">•Confirmation of diagnosis</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•First language, spoken language, number of languages spoken</td>
    <td rowspan="1" colspan="1">•Atypical Parkinsonian syndromes (MSA, PSP, CBD, DLB, FTD, ET)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Residence (house, institution, other)</td>
    <td rowspan="1" colspan="1">•Modified Hoehn and Yahr stage
     <sup>a</sup>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Situation (single, in relationship, other caregiver)</td>
    <td rowspan="1" colspan="1">•Asymmetry of symptoms</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Education</td>
    <td rowspan="1" colspan="1">•First and dominant symptoms (tremor, rigidity, bradykinesia, postural instability)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Smoking history</td>
    <td rowspan="1" colspan="1">•Presence of dyskinesia, motor fluctuations, motor block</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Alcohol and coffee consumption</td>
    <td rowspan="1" colspan="1">•History of fall</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Occupation and home location (urban, rural)</td>
    <td rowspan="1" colspan="1">•Anti-PD treatment history</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Environmental exposure to neurotoxins</td>
    <td rowspan="1" colspan="1">•RBD and sleep disorder</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Frequency of head trauma</td>
    <td rowspan="1" colspan="1">•Comorbidities (hypertension, hypotension, diabetes, constipation)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•MRI compatibility</td>
    <td rowspan="1" colspan="1">•Presence and treatment of psychiatric disorders (anxiety, depression, bipolar disorder, hallucinations, impulsive/compulsive behaviour)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">•Family history of PD and PD-related disease</td>
    <td rowspan="1" colspan="1">•Cognitive impairment</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1">•Presence of dementia</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>CBD, corticobasal degeneration; DLB, dementia with Lewy bodies; ET, essential tremor; FTD, frontotemporal dementia; MSA, multiple system atrophy; PD, Parkinson’s disease; PSP, progressive supranuclear palsy; RBD, REM (rapid eye movement) sleep behaviour disorder. 
   <sup>a</sup>Stages are described in 
   <xref ref-type="supplementary-material" rid="S1">Supplementary Table 1</xref>.
  </p>
 </table-wrap-foot>
</table-wrap>
